November 09 2022
Dr. Jong H. Jeong is a Professor of Biostatistics at the University of Pittsburgh and rejoined the NRG Oncology SDMC Pittsburgh Office on November 1, 2022. Previously, he has been actively involved in NRG Oncology working on B-30, B-31, B-33, and B-42 protocols as the primary statistician, or a co-investigator, and was also the primary statistician for the seminal update papers on B-04, B-14, and B-20 studies together with Dr. Bernard Fisher. While Dr. Jeong was away from NRG Oncology for several years, he served on leadership roles as the Interim Chair or Vice Chair of the Department of Biostatistics at the University of Pittsburgh.
Dr. Jeong’s main research area has been time-to-event analysis and clinical trials, both explanatory and pragmatic. His methodological papers have been published in well-respected journals in the field on a broad range of topics such as frailty models, weighted log-rank test, competing risks, quantile residual lifetime/life lost, likelihood theory such as empirical likelihood and hierarchical likelihood, and the win ratio for the analysis of the composite endpoint for semi-competing risks data. Dr. Jeong has a single-authored book on statistical inference on residual life and a co-authored book on analysis of survival data with random effects. His most recent research interests have been causal inference, deep learning, prediction modeling via various machine learning techniques, and survey sampling, for censored survival data. Dr. Jeong is a fellow of the American Statistical Association (ASA), an elected member of the International Statistical Institute (ISI), and an elected member of Omicron of the Delta Omega Society (Honorary Public Health Society).